OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Metabolic Modulation of the Tumor Microenvironment Leads to Multiple Checkpoint Inhibition and Immune Cell Infiltration
David Kolb, Nagesh Kolishetti, Bapurao Surnar, et al.
ACS Nano (2020) Vol. 14, Iss. 9, pp. 11055-11066
Closed Access | Times Cited: 98
David Kolb, Nagesh Kolishetti, Bapurao Surnar, et al.
ACS Nano (2020) Vol. 14, Iss. 9, pp. 11055-11066
Closed Access | Times Cited: 98
Showing 1-25 of 98 citing articles:
The cancer metabolic reprogramming and immune response
Longzheng Xia, Linda Oyang, Jinguan Lin, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 739
Longzheng Xia, Linda Oyang, Jinguan Lin, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 739
Mito‐Bomb: Targeting Mitochondria for Cancer Therapy
Xiaolu Guo, Naidi Yang, Wenhui Ji, et al.
Advanced Materials (2021) Vol. 33, Iss. 43
Closed Access | Times Cited: 315
Xiaolu Guo, Naidi Yang, Wenhui Ji, et al.
Advanced Materials (2021) Vol. 33, Iss. 43
Closed Access | Times Cited: 315
Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment
Guofeng Ma, Zhilei Zhang, Peng Li, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 116
Guofeng Ma, Zhilei Zhang, Peng Li, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 116
Mitochondria-Targeting Polymer Micelle of Dichloroacetate Induced Pyroptosis to Enhance Osteosarcoma Immunotherapy
Jiakang Jin, Pengcheng Yuan, Wei Yu, et al.
ACS Nano (2022) Vol. 16, Iss. 7, pp. 10327-10340
Closed Access | Times Cited: 101
Jiakang Jin, Pengcheng Yuan, Wei Yu, et al.
ACS Nano (2022) Vol. 16, Iss. 7, pp. 10327-10340
Closed Access | Times Cited: 101
Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncology
Jing‐Jing Yang, Anthony Griffin, Zhe Qiang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 90
Jing‐Jing Yang, Anthony Griffin, Zhe Qiang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 90
Statin shapes inflamed tumor microenvironment and enhances immune checkpoint blockade in non–small cell lung cancer
Wenjun Mao, Yun Cai, Danrong Chen, et al.
JCI Insight (2022) Vol. 7, Iss. 18
Open Access | Times Cited: 89
Wenjun Mao, Yun Cai, Danrong Chen, et al.
JCI Insight (2022) Vol. 7, Iss. 18
Open Access | Times Cited: 89
Nanoparticle‐Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor Efficacy
Wenyao Zhen, Ralph R. Weichselbaum, Wenbin Lin
Advanced Materials (2022) Vol. 35, Iss. 21
Open Access | Times Cited: 88
Wenyao Zhen, Ralph R. Weichselbaum, Wenbin Lin
Advanced Materials (2022) Vol. 35, Iss. 21
Open Access | Times Cited: 88
Engineering lactate-modulating nanomedicines for cancer therapy
Jiajie Chen, Yufang Zhu, Chengtie Wu, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 3, pp. 973-1000
Closed Access | Times Cited: 45
Jiajie Chen, Yufang Zhu, Chengtie Wu, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 3, pp. 973-1000
Closed Access | Times Cited: 45
Nanomedomics
Ganghao Liang, Wanqing Cao, Dongsheng Tang, et al.
ACS Nano (2024) Vol. 18, Iss. 17, pp. 10979-11024
Closed Access | Times Cited: 30
Ganghao Liang, Wanqing Cao, Dongsheng Tang, et al.
ACS Nano (2024) Vol. 18, Iss. 17, pp. 10979-11024
Closed Access | Times Cited: 30
Nanotechnology Reprogramming Metabolism for Enhanced Tumor Immunotherapy
Yangkai Zhou, Jing Yuan, Ke Xu, et al.
ACS Nano (2024) Vol. 18, Iss. 3, pp. 1846-1864
Closed Access | Times Cited: 20
Yangkai Zhou, Jing Yuan, Ke Xu, et al.
ACS Nano (2024) Vol. 18, Iss. 3, pp. 1846-1864
Closed Access | Times Cited: 20
Coordination Polymer‐Coated CaCO3 Reinforces Radiotherapy by Reprogramming the Immunosuppressive Metabolic Microenvironment
Chunjie Wang, Ziliang Dong, Hao Yu, et al.
Advanced Materials (2021) Vol. 34, Iss. 3
Closed Access | Times Cited: 84
Chunjie Wang, Ziliang Dong, Hao Yu, et al.
Advanced Materials (2021) Vol. 34, Iss. 3
Closed Access | Times Cited: 84
Mitochondria at Work: New Insights into Regulation and Dysregulation of Cellular Energy Supply and Metabolism
Volker Schirrmacher
Biomedicines (2020) Vol. 8, Iss. 11, pp. 526-526
Open Access | Times Cited: 71
Volker Schirrmacher
Biomedicines (2020) Vol. 8, Iss. 11, pp. 526-526
Open Access | Times Cited: 71
Remodelling of tumour microenvironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancer
Bihui Cao, Manting Liu, Lu Wang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 67
Bihui Cao, Manting Liu, Lu Wang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 67
Metabolic reprogramming due to hypoxia in pancreatic cancer: Implications for tumor formation, immunity, and more
Xiaodong Hao, Yidan Ren, Maoxiao Feng, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111798-111798
Open Access | Times Cited: 65
Xiaodong Hao, Yidan Ren, Maoxiao Feng, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111798-111798
Open Access | Times Cited: 65
Rationally designed monoamine oxidase A‐activatable AIE molecular photosensitizer for the specific imaging and cellular therapy of tumors
Yingcai Hu, Sheng‐Yan Yin, Wei Liu, et al.
Aggregate (2022) Vol. 4, Iss. 2
Open Access | Times Cited: 49
Yingcai Hu, Sheng‐Yan Yin, Wei Liu, et al.
Aggregate (2022) Vol. 4, Iss. 2
Open Access | Times Cited: 49
Mitochondrial dysfunction-targeted nanosystems for precise tumor therapeutics
Zhaoyu Ma, Heyou Han, Yanli Zhao
Biomaterials (2022) Vol. 293, pp. 121947-121947
Open Access | Times Cited: 49
Zhaoyu Ma, Heyou Han, Yanli Zhao
Biomaterials (2022) Vol. 293, pp. 121947-121947
Open Access | Times Cited: 49
Biomimetic Nanoplatform Loading Type I Aggregation-Induced Emission Photosensitizer and Glutamine Blockade to Regulate Nutrient Partitioning for Enhancing Antitumor Immunotherapy
Wei Xie, Bei Chen, Haifei Wen, et al.
ACS Nano (2022) Vol. 16, Iss. 7, pp. 10742-10753
Closed Access | Times Cited: 48
Wei Xie, Bei Chen, Haifei Wen, et al.
ACS Nano (2022) Vol. 16, Iss. 7, pp. 10742-10753
Closed Access | Times Cited: 48
VB12-Sericin-PBLG-IR780 Nanomicelles for Programming Cell Pyroptosis via Photothermal (PTT)/Photodynamic (PDT) Effect-Induced Mitochondrial DNA (mitoDNA) Oxidative Damage
Weihong Guo, Zhenhao Li, Huilin Huang, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 15, pp. 17008-17021
Closed Access | Times Cited: 47
Weihong Guo, Zhenhao Li, Huilin Huang, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 15, pp. 17008-17021
Closed Access | Times Cited: 47
ATP-exhausted nanocomplexes for intratumoral metabolic intervention and photoimmunotherapy
Mian Yu, Weiwei Zeng, Yaqi Ouyang, et al.
Biomaterials (2022) Vol. 284, pp. 121503-121503
Closed Access | Times Cited: 45
Mian Yu, Weiwei Zeng, Yaqi Ouyang, et al.
Biomaterials (2022) Vol. 284, pp. 121503-121503
Closed Access | Times Cited: 45
Inhibition of glycolysis-driven immunosuppression with a nano-assembly enhances response to immune checkpoint blockade therapy in triple negative breast cancer
Xijiao Ren, Zhuo Cheng, Jinming He, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 38
Xijiao Ren, Zhuo Cheng, Jinming He, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 38
π Bridge Engineering-Boosted Dual Enhancement of Type-I Photodynamic and Photothermal Performance for Mitochondria-Targeting Multimodal Phototheranostics of Tumor
Laiping Fang, Qi Meng, Yuan Zhang, et al.
ACS Nano (2023) Vol. 17, Iss. 21, pp. 21553-21566
Closed Access | Times Cited: 31
Laiping Fang, Qi Meng, Yuan Zhang, et al.
ACS Nano (2023) Vol. 17, Iss. 21, pp. 21553-21566
Closed Access | Times Cited: 31
Metabolic Reprogramming of NK Cells by Black Phosphorus Quantum Dots Potentiates Cancer Immunotherapy
Lizhen He, Jianfu Zhao, Hongjun Li, et al.
Advanced Science (2023) Vol. 10, Iss. 8
Open Access | Times Cited: 28
Lizhen He, Jianfu Zhao, Hongjun Li, et al.
Advanced Science (2023) Vol. 10, Iss. 8
Open Access | Times Cited: 28
OXPHOS-targeting drugs in oncology: new perspectives
Balaraman Kalyanaraman, Gang Cheng, Micaël Hardy, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 10, pp. 939-952
Open Access | Times Cited: 24
Balaraman Kalyanaraman, Gang Cheng, Micaël Hardy, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 10, pp. 939-952
Open Access | Times Cited: 24
Drug Delivery to the Brain: Recent Advances and Unmet Challenges
Sukanya Bhunia, Nagesh Kolishetti, Arti Vashist, et al.
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2658-2658
Open Access | Times Cited: 23
Sukanya Bhunia, Nagesh Kolishetti, Arti Vashist, et al.
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2658-2658
Open Access | Times Cited: 23
Tumor cell senescence-induced macrophage CD73 expression is a critical metabolic immune checkpoint in the aging tumor microenvironment
Yue Deng, Qingyan Chen, Xiao Yang, et al.
Theranostics (2024) Vol. 14, Iss. 3, pp. 1224-1240
Open Access | Times Cited: 15
Yue Deng, Qingyan Chen, Xiao Yang, et al.
Theranostics (2024) Vol. 14, Iss. 3, pp. 1224-1240
Open Access | Times Cited: 15
